Individuals Coming Off Anti-Obesity Injections Gain Back Weight Far More Rapidly Compared to Those on Conventional Diets

New research reveals that patients who stop using new slimming jabs like semaglutide or tirzepatide can put back on shed pounds far faster than those who stop traditional diet and exercise plans.

Research printed in a major health publication points out that while overweight individuals often shed a large proportion of their total mass while using the jabs, the mass returns at an estimated rate of 0.8 kg per month once they quit.

"Users purchasing such medications must be informed of the danger of fast weight regain when the therapy is stopped," stated expert Dr. Susan Jebb.

This pace of recovery implies a return to original mass within about one and a half years.

Analyzing Approaches

The research, which reviewed 37 of studies involving thousands of patients, contrasted the effects of GLP-1 agonists with older methods.

Researchers point out that individuals who lose weight through dieting generally experience a less rapid creep back—perhaps 0.1 kg a month—after stopping.

Explaining the Fast Rebound

Experts believe the mechanism of the drugs is key to understanding the accelerated weight return.

These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Sustained high doses of the hormone levels far above than normal might result in the body to generate a reduced amount of its own natural GLP-1, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Stopping of this hormone supplement means appetite is unsuppressed, making excessive eating far more likely."

A Chronic Issue?

The NHS suggest the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

Many experts say that, given the likelihood of relapse, the therapy might need to be life-long.

This opinion is supported by drug manufacturers, who note that the results "highlight the persistent nature of excess weight," similar to managing diseases like hypertension.

User Accounts

Users who have discontinued the jabs describe a intense resurgence of appetite.

"I experienced a switch activating and I was suddenly starving," described a patient.

This challenge is worsened if individuals have not adopted permanent lifestyle or habit modifications during therapy.

Growing Adoption

Recent estimates indicate that a significant number of adults in the UK have used these injections in the past year, with demand continuing to grow.

• Use is higher among women compared to men.
• The 40s and 50s demographic shows the highest level of interest.
• Many obtain the medications through private prescriptions rather than public health services.

Ultimately, clinicians caution that while the jabs are potent tools for weight loss, they are not a magic solution and long-term success hinges on integrated lifestyle changes.